UI- 16732763: Padmanabhan R. Etiology pathogenesis and prevention of neural tube defects. Congenit Anom (Kyoto) 2006 Jun;46(2):55-67.
UI- 16611162: Verrotti A, Tana M, Pelliccia P, Chiarelli F, Latini G. Recent advances on neural tube defects with special reference to Valproic Acid. Endocr Metab Immune Disord Drug Targets 2006 Mar;6(1):25-31.
UI- 16585338: Rader JI, Schneeman BO. Prevalence of neural tube defects, folate status, and folate fortification of enriched cereal-grain products in the United States. Pediatrics 2006 Apr;117(4):1394-9.
UI- 16569299: Jaques AM, Collins VR, Haynes K, Sheffield LJ, Francis I, Forbes R, Halliday JL. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects. J Med Screen 2006;13(1):8-13.
UI- 16528705: Bennett GD, Vanwaes J, Moser K, Chaudoin T, Starr L, Rosenquist TH. Failure of homocysteine to induce neural tube defects in a mouse model. BIrth Defects Res B Dev Reprod Toxicol 2006 Apr;77(2):89-94.
UI- 16300634: Gold V, Tsur A, Arad D, Weil M. Neural tube closure depends on nitric oxide synthase activity. J Neurochem 2006 Jan;96(1):247-53.
UI- 16143320: Netto CB, Portela LV, Felix TM, Souza DO, Goncalves CA, Giugliani R. Serum S100B levels in patients with neural tube defects. Clin Chim Acta 2006 Feb;364(1-2):275-8.
UI- 16423343: Mackay DR, Hu M, Li B, Rheaume C, Dai X. The mouse Ovo12 gene is required for cranial neural tube development. Dev Biol 2006 Mar 1;291(1):38-52.
UI- 16226775: Wlodarczyk BJ, Tang LS, Triplett A, Aleman F, Finnell RH. Spontaneous neural tube defects in splotch mice supplemented with selected micronutrients. Toxicol Appl Pharmacol 2006 May 15;213(1):55-63.
UI- 16112698: Dawson JE, Raymond AM, Winn LM. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice. Toxicol Appl Pharmacol 2006 Mar 1;211(2):124-32.
